Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.

Maryam Fath, Thomas Danne, Hanne Haahr, Torben Biester, Lars Erichsen, Olga Kordonouri. Pediatric Diabetes 2017; 1–8.
DOI 10.1111/pedi.12506
Ver comentario
Comentado por la Dra. Magdalena Mira. Residente de Endocrinología pediátrica, Pontificia Universidad Católica de Chile.